Anika Therapeutics, Inc. (NASDAQ:ANIK)

CAPS Rating: 2 out of 5

The Company develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair.

Recs

1
Player Avatar tunstavurn (< 20) Submitted: 3/2/2011 5:24:57 PM : Underperform Start Price: $9.19 ANIK Score: -311.83

Pending lawsuit with genzyme.declining marginsIncreased competition

Featured Broker Partners


Advertisement